VGI Health Technology (XNEC:VTL) Market Cap : A$0.00 Mil (As of May. 13, 2024)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). VGI Health Technology's share price for the quarter that ended in . 20 was A$. VGI Health Technology's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, VGI Health Technology's market cap for the quarter that ended in . 20 was A$ Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. VGI Health Technology's Enterprise Value for Today is A$0.00 Mil.

VGI Health Technology Market Cap Historical Data

The historical data trend for VGI Health Technology's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Market Cap Chart

VGI Health Technology Annual Data

Trend

Market Cap

VGI Health Technology Semi-Annual Data

Market Cap

Competitive Comparison of VGI Health Technology's Market Cap

For the Biotechnology subindustry, VGI Health Technology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VGI Health Technology's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's Market Cap distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's Market Cap falls into.

VGI Health Technology Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

VGI Health Technology's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )	=	Share Price (A: . 20 )	*	Shares Outstanding (EOP) (A: . 20 )
	=	A$	*
	=	A$

VGI Health Technology's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )	=	Share Price (Q: . 20 )	*	Shares Outstanding (EOP) (Q: . 20 )
	=	A$	*	0
	=	A$

VGI Health Technology (XNEC:VTL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

VGI Health Technology Market Cap Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines